ClinicalTrials.govpublic full text
Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.
non small cell lung cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 172291
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.